Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2008 (Vol. 28, No. 18)

Alliance for Cellular Signaling

URL:www.afcs.org
  • Online papers, databases
  • A bit light in places
Speaking of signaling, the Alliance for Cellular Signaling (AfCS) aims to “understand as completely as possible the relationships between sets of inputs and outputs in signaling cells that vary both temporally and spatially.” AfCS doesn’t try to cover all the news, though it does feature full-length research articles (PDF and HTML) and brief communications. In addition, the site provides access to several useful databases including the Yeast Two Hybrid Database, a Plasmid Database, an Antibody Database, and a Covalent Modification Database. Other features of the site appeared to be locked up behind a section that required login. No apparent options for free or paid registration were found, so how one gains access to the content is not clear.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »